H.R. 7966: Hospice Care Accountability, Reform, and Enforcement Act of 2026
The "Hospice Care Accountability, Reform, and Enforcement Act of 2026" aims to enhance the quality and oversight of hospice services under Medicare. Here are the key components of the bill:
Moratorium on New Hospice Programs
The bill establishes a five-year pause on the enrollment of new hospice programs in the Medicare system. This moratorium is intended to focus on improving the existing hospice care facilities rather than expanding the number of programs currently available.
Enhanced Oversight
To ensure better quality in hospice care, the legislation mandates stricter oversight measures. This includes:
- Implementing enhanced monitoring of hospice services.
- Improving the process for reporting and addressing issues related to care quality.
- Reforming ownership and payment processes to promote transparency and integrity within hospice programs.
Regulations for Palliative Therapies
The bill outlines specific regulations regarding palliative care therapies offered by hospice providers. This is intended to ensure that patients receive appropriate treatments aligned with their care needs.
Payment Adjustments and Care Requirements
New adjustments to payment structures for hospice care will be made under this bill. This includes:
- Setting requirements for developing a comprehensive plan of care for patients.
- Defining the conditions for respite care, which provides temporary relief for caregivers.
- Making changes to inpatient care requirements to ensure patients receive necessary services.
Home Respite Care and Reporting Duties
The legislation encourages the development of home respite care services, allowing family members and caregivers to have support without removing patients from their home environment. Additionally, hospice programs will face revised caps on payments and annual reporting responsibilities to maintain transparency regarding services offered and quality of care provided.
Relevant Companies
- HOSP - A company primarily involved in hospice care that could be directly impacted by the newly imposed oversight, regulations, and payment adjustments.
- AMED - This company operates in the home health and hospice sectors and might see changes due to the extended moratorium on new programs and the reforms related to inpatient care requirements.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 17, 2026 | Introduced in House |
| Mar. 17, 2026 | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.